Stock listing

NASDAQ:GEVA Synageva BioPharma Corp Stock

Follow Synageva BioPharma Corp into a list and get an email when it puts out news.

Last close · NASDAQ:GEVA

$238.60 USD

Close on Jun 22, 2015 · No longer trades

Jan 4, 1999 to last close +751.1% · monthly closes, Jan 4, 1999 – Jun 22, 2015
Lowest – highest close
$4.30 – $238.60 USDSince Jan 4, 1999 · lowest Jan 20, 2009 · highest Jun 22, 2015

Delisted NASDAQ:GEVA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:GEVA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Synageva BioPharma Corp on 6ix

Decks
6 decks · latest Jun 5, 2015

Decks

DeckKindSlidesDate
Merger or Acquisition (June 2015)Merger or acquisition31 slidesJun 5, 2015
Merger or Acquisition (May 2015)Merger or acquisition30 slidesMay 11, 2015
Merger or Acquisition (May 2015)Merger or acquisition20 slidesMay 6, 2015
Trimeris — Merger or Acquisition (September 2011)Merger or acquisition32 slidesSep 7, 2011
Trimeris — Merger or Acquisition (July 2011)Merger or acquisition19 slidesJul 27, 2011
Trimeris — Merger or Acquisition (July 2011)Merger or acquisition32 slidesJul 20, 2011

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Felix Baker
Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past)
Director · Aug 14, 2007 – Jun 22, 2015 · Past
Julian Baker
Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Seagen Inc (Director · Jun 9, 2006 – Dec 14, 2023 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past)
Director · Apr 25, 2006 – Jun 22, 2015 · Past
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past)
EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past
Stephen Davis
Other companies: Bellicum Pharmaceuticals Inc (Director · Jul 13, 2015 – Jan 3, 2023 · Past); ACADIA Pharmaceuticals Inc. (CEO, Director · Jul 15, 2014 – Aug 16, 2024 · Past); Furiex Pharmaceuticals Inc (Director · May 24, 2013 – Jul 2, 2014 · Past); Ardea Biosciences Inc (EVP & COO · Apr 6, 2010 – Jun 19, 2012 · Past); Heron Therapeutics, Inc. (Director · Feb 17, 2010 – Dec 16, 2022 · Past); Neurogen Corp (President, CEO, Director · Dec 15, 2006 – Jul 25, 2008 · Past)
Director · Jun 27, 2007 – Jun 22, 2015 · Past
Carsten Boess
Other companies: Atrium Therapeutics, Inc. (Director · Since at least Nov 10, 2025); Avidity Biosciences, Inc (Director · Since at least Jun 11, 2020); Rocket Pharmaceuticals, Inc. (Director · Since at least Jan 11, 2016); Orchestra BioMed Holdings, Inc. (Director · Aug 3, 2020 – Aug 3, 2020 · Past); Insulet Corporation (Vice President, International · May 14, 2007 – Apr 25, 2011 · Past)
SVP, Chief Financial Officer · Nov 2, 2011 – Jun 22, 2015 · Past
Arthur Bruce Cohen
Other companies: CareView Communications, Inc. (Director · Apr 21, 2011 – May 24, 2023 · Past)
Director · Feb 8, 2008 – Jul 23, 2009 · Past
Gary Cook
Other companies: Louisiana-Pacific Corporation (Director · Jun 26, 2006 – May 17, 2020 · Past)
Director · Aug 9, 2006 – Aug 9, 2006 · Past
Michael Glynn
Other companies: Pacific Biosciences of California, Inc. (Chief Commercial Officer · Oct 4, 2011 – Feb 15, 2012 · Past)
SVP, Global Commercial Ops. · Oct 30, 2012 – Jun 6, 2013 · Past
Steven D Skolsky
Other companies: Novan Inc (Director · Mar 1, 2021 – Jun 6, 2023 · Past)
Chief Executive Officer, Director · Jan 3, 2006 – Oct 2, 2006 · Past
Glen WilliamsSVP, Technical Operations · Sep 24, 2012 – Jun 22, 2015 · Past
All 11 people
PersonSeat
Hybrid Offshore HealthCorDirector · Jun 26, 2008 – Jul 23, 2009 · Past

Open People

Log in to ask 6ix AI your own questions about Synageva BioPharma Corp.